CClinicalTrials.gg
Not yet recruitingNCT07435545Updated Mar 2, 2026

Effect of Laughter Yoga on Menopausal Symptoms, Sleep, and Quality of Life in Menopausal Women

An interventional study of Laughter Yoga in Menopause, sponsored by Saglik Bilimleri Universitesi. Not yet recruiting at 1 site in Turkey (Türkiye). Open to female participants. Per ClinicalTrials.gov, last updated 2026-03-02.

Sponsored by Saglik Bilimleri Universitesi · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by Mar 2026, 6 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Sex
Female
01

Study summary

This study aims to provide meaningful contributions to both academic literature and clinical nursing practice by examining laughter yoga, a non-pharmacological, evidence-based, and feasible intervention for quality of life and sleep problems commonly encountered during menopause. Menopause is a natural stage of life that can be associated with physical and psychological symptoms affecting daily life. Laughter yoga, a group-based complementary method, is based on the philosophy that "movement creates emotion" and aims to transform voluntary laughter into natural and genuine laughter over time. Laughter yoga consists of clapping and warm-up exercises, childlike games, deep breathing techniques, laughter exercises, and meditation stages. Thanks to its physiological and psychological effects, it supports individuals' overall well-being.

In this study, participants will be divided into two groups: an intervention group and a control group. A pre-test will be administered to both groups to assess menopause symptoms, sleep quality, and quality of life. The intervention group will undergo eight sessions of laughter yoga, while the control group will not receive any intervention during the study period. A post-test will be administered to both groups after the intervention to evaluate its effectiveness.

The results of the study are expected to contribute to determining whether laughter yoga is an effective supportive approach during menopause. It is particularly important in terms of establishing a scientific basis for the integration of complementary treatment approaches into the menopause period and ensuring that they can be integrated with nursing care.

Read the detailed description

This study is designed as a controlled trial involving women in the menopause period, with participants individually randomized using a simple randomization method. The study will be conducted at a family health center affiliated with the Mamak Cultural Center Coordination in Ankara, Turkey.

Eligible participants will be randomly assigned to either the laughter yoga intervention group or the control group at a 1:1 ratio using a computer-generated randomization sequence. Following the pre-test, the intervention group will receive a total of eight laughter yoga sessions over four weeks, twice a week. No intervention will be administered to the control group during the study period.

Menopause symptoms, sleep quality, and menopause-specific quality of life will be assessed using pre-test and post-test measurements. This study aims to determine the effect of laughter yoga on changes experienced during menopause and on sleep and quality of life.

02

Conditions studied

  • Menopause

Keywords

  • Laughter Yoga
  • Menopause
  • Menopausal Symptoms
  • Sleep Quality
  • Quality of Life
  • Non-Pharmacological Intervention
  • Women's Health
  • Menopausal Women
03

In context

Sleep Initiation and Maintenance Disorders

1,856 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 594 are open to participants now.

This study's planned enrollment of 80 is close to the median of 73 across 1,631 interventional studies indexed under Sleep Initiation and Maintenance Disorders.

Browse Sleep Initiation and Maintenance Disorders studies →

Lead sponsor

Saglik Bilimleri Universitesi is the lead sponsor of 430 studies on the registry; 137 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Being in the menopause period
  • Having sufficient proficiency in understanding and expressing oneself in Turkish
  • Agreeing to participate in the study
  • Having physical and cognitive competence
  • Not having a diagnosis of mental disorder
  • Not using hormone therapy or complementary treatments for menopause symptoms

Exclusion criteria

Exclusion Criteria:

  • Not participating in laughter yoga sessions
  • Withdrawing from the study during the research phase
  • Incomplete filling out of data collection forms
  • Having contraindications for laughter yoga (Bleeding hemorrhoids, psychiatric disorders, epilepsy, undergoing surgery within the last 3 months, and similar conditions)
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Laughter Yoga Intervention Group

    Participants in the experimental group will undergo a pre-test to assess menopause symptoms, sleep, and quality of life. After 8 sessions of laughter yoga over 4 weeks, a post-test will be administered to reassess menopause symptoms, sleep, and quality of life.

    Behavioral: Laughter Yoga

  • No intervention
    Control Group

    Arm Description: No intervention will be applied to participants in this group during the study period. A pre-test will be administered at the beginning and a post-test will be administered after 4 weeks to assess menopause symptoms, sleep quality, and quality of life. After the final test, laughter yoga will be practiced to prevent participant bias.

Interventions

  • BehavioralLaughter Yoga

    The intervention consists of a total of 8 laughter yoga sessions, with 2 sessions per week for four weeks. Each laughter yoga session is planned to last an average of 20 minutes. Each session will begin with clapping and warm-up exercises and continue with childlike games, deep breathing exercises, and laughter exercises. It will end with meditation. It is a group-based practice, and the aim is to increase psychosocial well-being by transforming fake laughter into real laughter and to benefit from the physiological effects of laughter.

    Also known as: Laughter Therapy

06

What researchers measure

Primary outcomes

  1. Change in Menopausal Symptoms

    Menopause symptoms will be assessed using the Menopause Rating Scale (MRS). Changes in total MRS scores from baseline to post-intervention will be compared between the intervention group and the control group.

    Time frame: Baseline and immediately after the 4-week intervention

Secondary outcomes

  1. Change in Sleep Quality

    Sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI). Changes in PSQI scores at baseline and after the 4-week intervention will be compared between groups.

    Time frame: Baseline and immediately after the 4-week intervention

  2. Change in Menopause-Specific Quality of Life

    Quality of life will be assessed using the Menopause-Specific Quality of Life Questionnaire (MENQOL). Changes in MENQOL scores at baseline and after the 4-week intervention will be compared between the intervention and control groups.

    Time frame: Baseline and immediately after the 4-week intervention

07

Study locations

1 site
  • Mamak Aile Merkezleri
    Ankara, Ankara 06260, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data (IPD) underlying the results reported in publications, including the analyzable data set, will be shared if the study results are published.

Supporting information: Study protocol, Sap

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07435545
Lead sponsor
Saglik Bilimleri Universitesi
Responsible party
Derya Uzunca (Master's Student, Saglik Bilimleri Universitesi) — Principal investigator
First posted
Feb 27, 2026
Start date
Mar 1, 2026 (estimated)
Primary completion
Mar 29, 2026 (estimated)
Completion
Mar 29, 2026 (estimated)
Last update
Mar 2, 2026

Study contacts

Derya UZUNCA, BSc, RN
Contact
deryauzunca673@gmail.com
+905071720400
Prof. Dr. Gülten Güvenç, PhD
Contact
gulten.guvenc@sbu.edu.tr
Prof.Dr. Gülten Güvenç, PhD
principal investigator · Saglik Bilimleri Universitesi

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion